169 related articles for article (PubMed ID: 21387249)
1. [Prevalence of attention-deficit hyperactivity disorder in substance addiction: from screening to diagnosis].
Pedrero-Perez EJ; Ruiz-Sanchez de Leon JM; Rojo-Mota G; Llanero-Luque M; Puerta-Garcia C
Rev Neurol; 2011 Mar; 52(6):331-40. PubMed ID: 21387249
[TBL] [Abstract][Full Text] [Related]
2. Adult ADHD and substance abuse: diagnostic and treatment issues.
Kalbag AS; Levin FR
Subst Use Misuse; 2005; 40(13-14):1955-81, 2043-8. PubMed ID: 16282088
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis.
van Emmerik-van Oortmerssen K; van de Glind G; van den Brink W; Smit F; Crunelle CL; Swets M; Schoevers RA
Drug Alcohol Depend; 2012 Apr; 122(1-2):11-9. PubMed ID: 22209385
[TBL] [Abstract][Full Text] [Related]
4. The dual diagnosis of attention-deficit/hyperactivity disorder and substance abuse: case reports and literature review.
Schubiner H; Tzelepis A; Isaacson JH; Warbasse LH; Zacharek M; Musial J
J Clin Psychiatry; 1995 Apr; 56(4):146-50. PubMed ID: 7713853
[TBL] [Abstract][Full Text] [Related]
5. [Attention-deficit/hyperactivity disorder and substance abuse].
Davids E; Gastpar M
Psychiatr Prax; 2003 May; 30(4):182-6. PubMed ID: 12768521
[TBL] [Abstract][Full Text] [Related]
6. Features and prevalence of patients with probable adult attention deficit hyperactivity disorder who request treatment for cocaine use disorders.
Pérez de Los Cobos J; Siñol N; Puerta C; Cantillano V; López Zurita C; Trujols J
Psychiatry Res; 2011 Jan; 185(1-2):205-10. PubMed ID: 20537723
[TBL] [Abstract][Full Text] [Related]
7. ADHD in adult psychiatry. Minimum rates and clinical presentation in general psychiatry outpatients.
Nylander L; Holmqvist M; Gustafson L; Gillberg C
Nord J Psychiatry; 2009; 63(1):64-71. PubMed ID: 18991159
[TBL] [Abstract][Full Text] [Related]
8. [Attention deficit hyperactivity disorder (ADHD) and addiction].
Hässler F; Reis O
MMW Fortschr Med; 2010 May; 152(18):46-8. PubMed ID: 20514764
[No Abstract] [Full Text] [Related]
9. Comorbidity of alcohol and substance dependence with attention-deficit/hyperactivity disorder (ADHD).
Ohlmeier MD; Peters K; Te Wildt BT; Zedler M; Ziegenbein M; Wiese B; Emrich HM; Schneider U
Alcohol Alcohol; 2008; 43(3):300-4. PubMed ID: 18326548
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic accuracy of attention-deficit/hyperactivity disorder in adults with substance use disorders.
Fatseas M; Debrabant R; Auriacombe M
Curr Opin Psychiatry; 2012 May; 25(3):219-25. PubMed ID: 22449768
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of a special consultation for attention deficit/hyperactivity disorder in adults].
Davids E; Krause DA; Specka M; Gastpar M
Gesundheitswesen; 2004 Jul; 66(7):416-22. PubMed ID: 15314733
[TBL] [Abstract][Full Text] [Related]
12. Diagnosing attention-deficit/hyperactivity disorder in patients with substance use disorders.
Levin FR
J Clin Psychiatry; 2007; 68 Suppl 11():9-14. PubMed ID: 18307376
[TBL] [Abstract][Full Text] [Related]
13. [Validation in the adult Spanish population of the Wender Utah Rating Scale for the retrospective evaluation in adults of attention deficit/hyperactivity disorder in childhood].
Rodríguez-Jiménez R; Ponce G; Monasor R; Jiménez-Giménez M; Pérez-Rojo JA; Rubio G; Jiménez Arriero ; Palomo T
Rev Neurol; 2001 Jul 16-31; 33(2):138-44. PubMed ID: 11562873
[TBL] [Abstract][Full Text] [Related]
14. Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology.
Spencer TJ; Biederman J; Mick E
Ambul Pediatr; 2007; 7(1 Suppl):73-81. PubMed ID: 17261486
[TBL] [Abstract][Full Text] [Related]
15. Anxiety disorders moderate the association between externalizing problems and substance use disorders: data from the National Comorbidity Survey-Revised.
Hofmann SG; Richey JA; Kashdan TB; McKnight PE
J Anxiety Disord; 2009 May; 23(4):529-34. PubMed ID: 19059752
[TBL] [Abstract][Full Text] [Related]
16. An examination of the psychometric properties of the attention deficit scales for adults with outpatient substance abusers.
West SL; Mulsow M; Arredondo R
Am J Drug Alcohol Abuse; 2007; 33(5):755-64. PubMed ID: 17891668
[TBL] [Abstract][Full Text] [Related]
17. Screening and imputed prevalence of ADHD in adult patients with comorbid substance use disorder at a residential treatment facility.
Adler LA; Guida F; Irons S; Rotrosen J; O'Donnell K
Postgrad Med; 2009 Sep; 121(5):7-10. PubMed ID: 19820269
[TBL] [Abstract][Full Text] [Related]
18. Clinical assessment and diagnosis of adults with attention-deficit/hyperactivity disorder.
Haavik J; Halmøy A; Lundervold AJ; Fasmer OB
Expert Rev Neurother; 2010 Oct; 10(10):1569-80. PubMed ID: 20925472
[TBL] [Abstract][Full Text] [Related]
19. Comorbid attention-deficit/hyperactivity disorder in borderline patients defines an impulsive subtype of borderline personality disorder.
Ferrer M; Andión O; Matalí J; Valero S; Navarro JA; Ramos-Quiroga JA; Torrubia R; Casas M
J Pers Disord; 2010 Dec; 24(6):812-22. PubMed ID: 21158602
[TBL] [Abstract][Full Text] [Related]
20. Bipolar disorders and quality of life: the impact of attention deficit/hyperactivity disorder and substance abuse in euthymic patients.
Sentissi O; Navarro JC; De Oliveira H; Gourion D; Bourdel MC; Baylé FJ; Olié JP; Poirier MF
Psychiatry Res; 2008 Oct; 161(1):36-42. PubMed ID: 18786727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
